Publicaciones en las que colabora con JOSÉ ANTONIO RAMOS ATANCE (56)

2023

  1. El gen del receptor cannabinoide tipo 2 se asocia con la comorbilidad entre esquizofrenia y dependencia de cannabis y el gen de la enzima amidohidrolasa de ácidos grasos se asocia con la dependencia de cannabis en población española

    Adicciones: Revista de socidrogalcohol, Vol. 35, Núm. 1, pp. 33-45

2022

  1. ¿Es posible crear la adecuada sensación de riesgo entre los consumidores de cannabis medicinal?

    Adicciones: Revista de socidrogalcohol, Vol. 34, Núm. 4, pp. 253-257

2017

  1. Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3

    PLoS ONE, Vol. 12, Núm. 4

  2. Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies

    Methods in Enzymology (Academic Press Inc.), pp. 175-198

2016

  1. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

    Neuroscience, Vol. 339, pp. 191-209

2010

  1. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders

    CNS Neuroscience and Therapeutics, Vol. 16, Núm. 3

  2. Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 153, Núm. 1, pp. 79-85

2009

  1. Casos clínicos en psiquiatría relacionados con el consumo de cannabis

    Sociedad Española de Investigación en Cannabinoides (SEIC)

2008

  1. Aspectos psiquiátricos del consumo de cannabis: casos clínicos

    Sociedad Española de Investigación en Cannabinoides (SEIC)

2007

  1. An overview on the biochemistry of the cannabinoid system

    Molecular Neurobiology, Vol. 36, Núm. 1, pp. 3-14

2005

  1. Effects on development

    Handbook of Experimental Pharmacology, Vol. 168, pp. 643-656

  2. Therapeutic potential of the endocannabinoid system in the brain

    Mini-Reviews in Medicinal Chemistry, Vol. 5, Núm. 7, pp. 609-617

2004

  1. Behavioral and molecular changes elicited by acute administration of SR141716 to Δ 9 -tetrahydrocannabinol-tolerant rats: An experimental model of cannabinoid abstinence

    Drug and Alcohol Dependence, Vol. 74, Núm. 2, pp. 159-170

  2. Cannabinoids and gene expression during brain development

    Neurotoxicity Research, Vol. 6, Núm. 5, pp. 389-401

2003

  1. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain.

    Brain research. Developmental brain research, Vol. 147, Núm. 1-2, pp. 201-207

2002

  1. Changes in prodynorphin and POMC gene expression in several brain regions of rat fetuses prenatally exposed to Δ9-tetrahydrocannabinol

    Neurotoxicity Research, Vol. 4, Núm. 3, pp. 211-218

  2. Exposure to cannabinoids in the development of endogenous cannabinoid system

    Neurotoxicity Research, Vol. 4, Núm. 4, pp. 363-372

  3. Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease

    Neurotoxicity Research, Vol. 4, Núm. 7-8, pp. 601-608

2000

  1. Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme

    Brain Research, Vol. 857, Núm. 1-2, pp. 56-65

  2. The endogenous cannabinoid system and brain development

    Trends in Neurosciences, Vol. 23, Núm. 1, pp. 14-20